标题
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 5, Pages 4268
出版商
MDPI AG
发表日期
2023-02-21
DOI
10.3390/ijms24054268
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality
- (2023) Benjamin N Wadström et al. EUROPEAN HEART JOURNAL
- Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy
- (2022) Paul M Ridker et al. CIRCULATION
- Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID‐REAL registry
- (2022) Alberto Cordero et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Association of remnant cholesterol and lipid parameters with new-onset carotid plaque in Chinese population
- (2022) Bo Liu et al. Frontiers in Cardiovascular Medicine
- Remnant cholesterol is associated with cardiovascular mortality
- (2022) Kerui Zhang et al. Frontiers in Cardiovascular Medicine
- Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
- (2022) Samuel C. R. Sherratt et al. Current Atherosclerosis Reports
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
- (2022) Bradley Field Bale et al. Frontiers in Cardiovascular Medicine
- Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?
- (2021) Francesco Angelico et al. DIGESTIVE AND LIVER DISEASE
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
- (2021) Renato Quispe et al. EUROPEAN HEART JOURNAL
- Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction
- (2021) Anette Varbo et al. EUROPEAN HEART JOURNAL
- Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study
- (2021) Benjamin Nilsson Wadström et al. EUROPEAN HEART JOURNAL
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
- (2020) Børge G. Nordestgaard et al. ATHEROSCLEROSIS
- Contribution of remnant cholesterol to cardiovascular risk
- (2020) Anne Langsted et al. JOURNAL OF INTERNAL MEDICINE
- Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
- (2020) Ron C Hoogeveen et al. CLINICAL CHEMISTRY
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- (2020) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease
- (2020) Olga Castañer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. ATHEROSCLEROSIS
- Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial
- (2018) Antonio J. Vallejo-Vaz et al. CIRCULATION
- Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
- (2018) Michel R. Langlois et al. CLINICAL CHEMISTRY
- Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
- (2018) Anum Saeed et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
- (2018) Daniele Pastori et al. Journal of Clinical Medicine
- Postprandial Hyperlipidemia and Remnant Lipoproteins
- (2017) Daisaku Masuda et al. Journal of Atherosclerosis and Thrombosis
- Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease
- (2017) Si Van Nguyen et al. Journal of Cardiology
- PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress
- (2017) Guido Carpino et al. Scientific Reports
- Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
- (2017) Patrick R. Lawler et al. Journal of the American Heart Association
- Non-HDL Cholesterol and TriglyceridesHighlights
- (2016) Rishi Puri et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease
- (2016) A.-M. K. Jepsen et al. CLINICAL CHEMISTRY
- Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints--A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
- (2016) B. G. Nordestgaard et al. CLINICAL CHEMISTRY
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Residual cardiovascular risk
- (2016) Roberto Ferrari et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies
- (2016) Parag H. Joshi et al. Journal of the American Heart Association
- Nonfasting for Routine Lipid Testing
- (2016) Samia Mora JAMA Internal Medicine
- Nonfasting Lipid Profiles: The Way of the Future
- (2015) A. Langsted et al. CLINICAL CHEMISTRY
- Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population
- (2015) A. Varbo et al. CLINICAL CHEMISTRY
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- LDL Cholesterol as a Predictor of Mortality, and Beyond
- (2014) Robert H. Eckel CIRCULATION
- High Remnant Lipoprotein Predicts Recurrent Cardiovascular Events on Statin Treatment After Acute Coronary Syndrome
- (2014) Si Van Nguyen et al. CIRCULATION JOURNAL
- Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
- (2013) Eliot A Brinton et al. Cardiovascular Diabetology
- Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
- (2013) Anette Varbo et al. CIRCULATION
- Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
- (2013) Seth S. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Triglyceride-Rich Lipoprotein Modulates Endothelial Vascular Cell Adhesion Molecule (VCAM)-1 Expression via Differential Regulation of Endoplasmic Reticulum Stress
- (2013) Ying I. Wang et al. PLoS One
- Should We Fast Before We Measure Our Lipids?
- (2012) J. Michael Gaziano ARCHIVES OF INTERNAL MEDICINE
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals
- (2011) Takamitsu Nakamura et al. ATHEROSCLEROSIS
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- The epidemiological concept of residual risk
- (2011) Diego Vanuzzo Internal and Emergency Medicine
- Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
- (2008) Samia Mora et al. CIRCULATION
- Fasting and Nonfasting Lipid Levels
- (2008) Anne Langsted et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now